Masters of Longevity - The Pulse

PR Newswire18 Jun 2026
AIHuawei Expands Health and Fitness Ecosystem on HUAWEI WATCH FIT 5 Series, Deepening Commitment to Women (PR Newswire)

Huawei Expands Health and Fitness Ecosystem on HUAWEI WATCH FIT 5 Series, Deepening Commitment to Women

New wearable integrations expand women's health and fitness apps, developer tools, and subscription incentives to broaden the platform's app ecosystem reach.

Key takeaways
  • Applications are available through HUAWEI AppGallery across all models of the HUAWEI WATCH FIT 5 Series.
  • New HUAWEI WATCH FIT 5 Series buyers will receive an exclusive three-month premium subscription.
  • Founded by renowned running coach Candela Pérez.
Longevity Technology18 Jun 2026
AIAlzeCure clears key hurdle for drug targeting Alzheimer’s and depression (Longevity Technology)

AlzeCure clears key hurdle for drug targeting Alzheimer’s and depression

Read about clinical progress demonstrating safety and CNS exposure for a neurotrophic small molecule targeting dementia and mood disorders.

Key takeaways
  • ACD856 was well tolerated with no substance-related safety findings.
  • Results support Phase II studies expected in 2026 following a 2025 European Innovation Council grant.
  • Repeated higher dosing produced expected increases in blood and cerebrospinal fluid concentrations.
Science Daily - Health & Medicine18 Jun 2026
Researchers found 8 common food additives linked to high blood pressure and heart disease (Science Daily - Health & Medicine)

Researchers found 8 common food additives linked to high blood pressure and heart disease

Food preservatives and heart health are examined through new research analysis. Expect clear methods, context, and implications for dietary guidance.

Key takeaways
  • NutriNet‑Santé cohort included 112,395 participants with about seven to eight years follow-up.
  • Highest intake of non‑antioxidant preservatives linked to 29% higher hypertension risk.
  • Eight specific preservatives were associated with increased hypertension risk in the analysis.
Longevity Technology18 Jun 2026
AIResolution Therapeutics extends inflammatory and fibrotic pipeline (Longevity Technology)

Resolution Therapeutics extends inflammatory and fibrotic pipeline

Biotech strategy update — see how a company is positioning complementary therapeutic platforms to broaden treatment options for inflammatory and fibrotic diseases.

Key takeaways
  • Material transfer agreements were signed with independent LNP providers for in vivo myeloid engineering.
  • Systematic parallel assessments of LNP vehicles will run while proprietary mRNA payloads are finalized.
  • Preliminary LNP assessment results and interim clinical data are expected later this year.